NetworkNewsBreaks

ThursdayAug 27, 2020 11:07 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Editorial Projecting Significant Growth for Global Brain Tumor Therapeutics Sector

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, was featured in an editorial by Financial News Media. The piece, titled “Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025,” covers CNSP and other biotech and pharma companies, including Mallinckrodt plc (NYSE: MNK), Amarin Corporation plc (NASDAQ: AMRN), Merck (NYSE: MRK) and Immunic Inc. (NASDAQ: IMUX), which are active in the market. Several industry analysts project continued growth in the global brain tumor therapeutics sector, with one such report projecting…

Continue Reading

ThursdayAug 27, 2020 10:56 am

NetworkNewsBreaks – Karuna Therapeutics, Inc. (NASDAQ: KRTX) Featured in Mizuho Securities Research Report

Karuna Therapeutics (NASDAQ: KRTX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We spoke with several investors as well as company management following the weakness in Karuna shares that followed the announcement that top holder PureTech (Not Covered) has obtained permission from its shareholders to sell its Karuna holdings and that it sold ~$100M worth of Karuna shares through a block trade. Based on our conversation with management and our review of the situation, we remain bullish on Karuna's outlook. We continue to see it as a Top Pick in our…

Continue Reading

ThursdayAug 27, 2020 10:30 am

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Announces Participation Schedule for September Investor Conferences

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, recently announced its plans to participate in investor conferences during the month of September 2020. According to the update, SGLB will participate in the LD 500 Virtual Investor Conference slated to take place from September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020. Sigma Labs CEO Mark K. Ruport will host a virtual presentation and participate in one-on-one meetings, and management will highlight its recent contract award with Mitsubishi Heavy Industries and other end users in a…

Continue Reading

ThursdayAug 27, 2020 10:07 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) VP Scheduled to Present During Prestigious LD 500 Virtual Event

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a B2B global vendor of next-generation, push-to-talk over cellular (“PTT”) devices and cellular booster systems, will be participating at the upcoming LD 500 Virtual Conference. The four-day gathering, slated for Sept. 1–4, 2020, and featuring some of the most prominent companies in the micro-cap world, is the most ambitious event yet for the LD event group. Siyata Mobile’s vice president of corporate development, Daniel Kim, will be presenting during the premiere event, held online for the first time. His 20-minute live presentation is scheduled for Friday, Sept. 4, at 6:20 a.m. PST (9:20 a.m.…

Continue Reading

ThursdayAug 27, 2020 9:42 am

NetworkNewsBreaks – Target Corp. (NYSE: TGT) Featured in Analysis Report

Following impressive financial results from both Walmart Inc. (NYSE: WMT) and The Home Depot Inc. (NYSE: HD), Target (NYSE: TGT) was featured in an analysis report ahead of its recently reported second quarter 2020 results (http://nnw.fm/Wg8NM). The August 18th report, written by LikeFolio Founder Andy Swan, reads, “Purchase Intent in 20Q2 increased by 13% YoY. Now, Purchase Intent has almost completely normalized. While +13% demand growth is impressive, it is important to note this is smaller than what we observed for WMT in the same quarter (+32% YoY).” About Target Minneapolis-based Target Corporation serves guests at nearly 1,900 stores and…

Continue Reading

ThursdayAug 27, 2020 9:27 am

NetworkNewsBreaks – Nordstrom, Inc. (NYSE: JWN) Featured in Analysis Report

Nordstrom (NYSE: JWN) was featured in an analysis report highlighting the company’s performance ahead of it recently reported financial results for the second quarter of 2020. The report, written by LikeFolio Founder Andy Swan, reads, “Nordstrom's Anniversary sale is typically a predictive indicator for the company's future performance. This year, the event was shifted from July to August. This means the 2019 anniversary sale occurred in 19Q2, and the 2020 anniversary sale is currently underway in 20Q3. So far, Nordstrom Anniversary Sales Purchase Intent mentions are 22% lower YoY. This timing shift and COVID-related store closures paint an unusual picture…

Continue Reading

ThursdayAug 27, 2020 9:00 am

NetworkNewsBreaks – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Appoints Dr. Patrick Wen to Science Advisory Board

CNS Pharmaceuticals (NASDAQ: CNSP) (“CNS”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, this morning announced the appointment of Patrick Wen, M.D., an accomplished neuro-oncologist, to the company’s Science Advisory Board. “We are excited to add Dr. Wen, a neuro-oncologist with a passion for and background in investigating cures for deadly brain cancers, such as glioblastoma, to our Science Advisory Board,” CNS Pharmaceuticals CEO John Climaco stated in the news release. “We believe Dr. Wen's extensive experience in the field of neuro-oncology will prove invaluable as…

Continue Reading

WednesdayAug 26, 2020 2:49 pm

NetworkNewsBreaks – Cybin Corp. Poised Amid Groundbreaking Decision to Allow Psilocybin Therapy

Cybin Corp., an exemplary Canada-based life-science company focused on the development of pharmaceutical-grade psilocybin products, appears ideally positioned to leverage a milestone moment. Canada’s Minister of Health, the Honourable Patty Hajdu, recently approved the use of psilocybin therapy in the end-of-life treatment of four Canadians battling incurable cancer (http://nnw.fm/JVZYJ), and this groundbreaking decision bodes well for companies such as Cybin, which are operating in the sector. The approval marks the first known, legal medical exemption for psilocybin use in Canada since the compound became illegal in the country in 1974. A recent article discussing this anticipates more applications through the…

Continue Reading

WednesdayAug 26, 2020 2:13 pm

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Positioned to Compete in ‘Largely Untapped US Market’

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, recently completed a round of successful fundraising that will assist in expanding the availability of its platform. DarioHealth secured approximately $28.6 million in aggregate gross proceeds from health-care funds and institutions across the United States and Israel through the private-placement transaction with accredited investors. The new capital coupled with existing cash  puts the company in its best financial state since its inception (http://nnw.fm/wmeZq). A recent article discussing this quotes Dario CEO Erez Raphael, who stated, “We are pleased to have the confidence of our largest shareholder…

Continue Reading

WednesdayAug 26, 2020 1:55 pm

NetworkNewsBreaks – Deltec Bank & Trust Ltd. Delves Into Intricacies Surrounding EU Recovery Fund

Deltec Bank & Trust, recently named the Best Private Bank Caribbean 2020 (http://nnw.fm/0dD3d), has published its latest investment research note entitled “EUreka” (http://nnw.fm/FtDJU). In the piece, Deltec looks into the intricacies around the European Union’s (“EU”) proactive fiscal response in dealing with the ongoing coronavirus outbreak and its impact on Eurozone financial-asset prices and the Euro. Deltec believes that the EU’s actions will benefit the government bonds and Europe’s weaker economies in the long term, with over-strained fiscal budgets set to be subsidized by the recovery-fund mechanism. A recent article discussing this reads, “Today, following the historic introduction of the…

Continue Reading